Sub-Saharan Africans infected with HIV-1C make up the largest AIDS patient population in the world and exhibit large heterogeneity in disease progression before initiating antiretroviral therapy. To identify host variants associated with HIV disease progression, we performed genome-wide association studies on a total of 556 treatment-naive HIV-infected individuals in Botswana. We characterized the pattern of HIV disease progression using a novel functional principal component analysis, which can better capture longitudinal CD4 and viral load (VL) trajectories. Two single-nucleotide polymorphisms (SNPs) near HCG22 (chr6, peak variant rs2535307, combined p = 3.72 × 10−7, minor allele as risky allele) and CCNG1 (chr5, peak variant kgp22385164, combined p = 1.88 × 10−6, minor allele as risky allele) were significantly associated with CD4 and VL dynamics. Inspection of SNPs in these gene regions in a third Botswana cohort (using GWATCH) also revealed a strong association of HCG22 with HIV-1C acquisition, suggesting that this region is associated with infection as well as disease progression. Our study uncovered two genetic regions that are significant and have specific effects on HIV-1C acquisition or progression in sub-Saharan Africans, and the result suggested new potential targets for AIDS prevention and treatment. In addition, our results also indicate the possibility of using genetic markers as HIV disease progression indicators in sub-Saharan Africans to prioritize fast progressors for antiretroviral treatment.
Get full access to this article
View all access options for this article.
References
1.
GerettiAM: HIV-1 subtypes: Epidemiology and significance for HIV management. Curr Opin Infect Dis, 2006; 19:1–7.
2.
UNAIDS: Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. UNAIDS, Geneva, 2013.
FellayJ, ShiannaKV, GeD, ColomboS, LedergerberB, WealeM, ZhangK, GumbsC, CastagnaA, CossarizzaA, Cozzi-LepriA, De LucaA, EasterbrookP, FrancioliP, MallalS, Martinez-PicadoJ, MiroJM, ObelN, SmithJP, WynigerJ, DescombesP, AntonarakisSE, LetvinNL, McMichaelAJ, HaynesBF, TelentiA, GoldsteinDB: A whole-genome association study of major determinants for host control of HIV-1. Science, 2007; 317:944–947.
5.
van ManenD, KootstraNA, Boeser-NunninkB, HandulleMA, van't WoutAB, SchuitemakerH: Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS, 2009; 23:19–28.
6.
MiguelesSA, SabbaghianMS, ShupertWL, BettinottiMP, MarincolaFM, MartinoL, HallahanCW, SeligSM, SchwartzD, SullivanJ, ConnorsM: HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A, 2000; 97:2709–2714.
7.
DalmassoC, CarpentierW, MeyerL, RouziouxC, GoujardC, ChaixML, LambotteO, Avettand-FenoelV, Le ClercS, de SennevilleLD, DeveauC, BoufassaF, DebreP, DelfraissyJF, BroetP, TheodorouI; ANRS Genome Wide Association 01: Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: The ANRS Genome Wide Association 01 study. PLoS One, 2008; 3:e3907.
YaoF: Functional principle component analysis for longitudinal and survival data. Stat Sin, 2007; 17:965–983.
17.
JamesGM, HastieTJ, SugarCA: Principal component models for sparse functional data. Biometrika, 2000; 87:587–602.
18.
YaoF, MüllerH-G, WangJ-L: Functional data analysis for sparse longitudinal data. J Am Stat Assoc, 2005; 100:577–590.
19.
WuS, MüllerH-G: Response-adaptive regression for longitudinal data. Biometrics, 2011; 67:852–860.
20.
BaumMK, CampaA, LaiS, Sales MartinezS, TsalaileL, BurnsP, FarahaniM, LiY, van WidenfeltE, PageJB, BussmannH, FawziWW, MoyoS, MakhemaJ, ThiorI, EssexM, MarlinkR: Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: A randomized clinical trial. JAMA, 2013; 310:2154–2163.
21.
PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, ReichD: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet, 2006; 38:904–909.
22.
SvitinA, MalovS, CherkasovN, GeertsP, RotkevichM, DobryninP, ShevchenkoA, GuanL, TroyerJ, HendricksonS, DilksH, OleksykT, DonfieldS, GompertsE, JabsD, SezginE, Van NattaM, HarriganP, BrummeZ, O'BrienS: GWATCH: A web platform for automated gene association discovery analysis. Gigascience, 2014; 3:18.
23.
ShapiroRL, ThiorI, GilbertPB, LockmanS, WesterC, SmeatonLM, StevensL, HeymannSJ, Ndung'uT, GaseitsiweS, NovitskyV, MakhemaJ, LagakosS, EssexM: Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS, 2006; 20:1281–1288.
24.
ThiorI, LockmanS, SmeatonLM, ShapiroRL, WesterC, HeymannSJ, GilbertPB, StevensL, PeterT, KimS, van WidenfeltE, MoffatC, NdaseP, ArimiP, KebaabetsweP, MazondeP, MakhemaJ, McIntoshK, NovitskyV, LeeTH, MarlinkR, LagakosS, Essex M; Mashi StudyTeam: Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: A randomized trial: The Mashi Study. JAMA, 2006; 296:794–805.
25.
NovitskyV, LagakosS, HerzigM, BonneyC, KebaabetsweL, RossenkhanR, NkweD, MargolinL, MusondaR, MoyoS, WoldegabrielE, van WidenfeltE, MakhemaJ, EssexM: Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. Virology, 2009; 383:47–59.
26.
NovitskyV, WangR, KebaabetsweL, GreenwaldJ, RossenkhanR, MoyoS, MusondaR, WoldegabrielE, LagakosS, EssexM: Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. J Acquir Immune Defic Syndr, 2009; 52:265–272.
27.
NovitskyV, WangR, MargolinL, BacaJ, KebaabetsweL, RossenkhanR, BonneyC, HerzigM, NkweD, MoyoS, MusondaR, WoldegabrielE, van WidenfeltE, MakhemaJ, LagakosS, EssexM: Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection. PLoS One, 2009; 4:e7727.
28.
NovitskyV, WoldegabrielE, KebaabetsweL, RossenkhanR, MlotshwaB, BonneyC, FinucaneM, MusondaR, MoyoS, WesterC, van WidenfeltE, MakhemaJ, LagakosS, EssexM: Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr, 2009; 50:65–76.
29.
NovitskyV, WoldegabrielE, WesterC, McDonaldE, RossenkhanR, KetunutiM, MakhemaJ, SeageGR3rd, EssexM: Identification of primary HIV-1C infection in Botswana. AIDS Care, 2008; 20:806–811.
30.
JamesGM: Generalized linear models with functional predictors. J R Stat Soc Series B Stat Methodol, 2002; 64:411–432.
31.
RiceJA, SilvermanBW: Estimating the mean and covariance structure nonparametrically when the data are curves. J R Stat Soc Series B Stat Methodol, 1991; 53:233–243.
32.
HallP, MüllerH-G, WangJ-L: Properties of principal component methods for functional and longitudinal data analysis. Ann Stat, 2006; 34:1493–1517.
33.
RobinsonGK: That BLUP is a good thing: The estimation of random effects. Stat Sci, 1991; 6:15–32.
34.
HolteS, RandolphT, DingJ, TienJ, McClellandR, BaetenJ, OverbaughJ: Efficient use of longitudinal CD4 counts and viral load measures in survival analysis. Stat Med, 2012; 31:2086–2097.
35.
ZhangZ, ErsozE, LaiCQ, TodhunterRJ, TiwariHK, GoreMA, BradburyPJ, YuJ, ArnettDK, OrdovasJM, BucklerES: Mixed linear model approach adapted for genome-wide association studies. Nat Genet, 2010; 42:355–360.
36.
LairdNM, WareJH: Random-effects models for longitudinal data. Biometrics, 1982; 38:963–974.
37.
SmithEN, ChenW, KahonenM, KettunenJ, LehtimakiT, PeltonenL, RaitakariOT, SalemRM, SchorkNJ, ShawM, SrinivasanSR, TopolEJ, ViikariJS, BerensonGS, MurraySS: Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet, 2010; 6:e1001094.
38.
LinX: Variance component testing in generalised linear models with random effects. Biometrika, 1997; 84:309–326.
39.
WuMC, LeeS, CaiT, LiY, BoehnkeM, LinX: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet, 2011; 89:82–93.
40.
BenjaminiY, HochbergY: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol, 1995; 57:289–300.
YeungML, HouzetL, YedavalliVS, JeangKT: A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem, 2009; 284:19463–19473.
45.
Le ClercS, LimouS, CoulongesC, CarpentierW, DinaC, TaingL, DelaneauO, LabibT, Sladek RAN, RS GenomicGroup, DeveauC, GuillemainH, RatsimandresyR, MontesM, SpadoniJL, TherwathA, SchachterF, MatsudaF, GutI, LelievreJD, LevyY, FroguelP, DelfraissyJF, HercbergS, ZaguryJF: Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis, 2009; 200:1194–1201.
46.
ZhangHS, RuanZ, SangWW: HDAC1/NFkappaB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. J Cell Physiol, 2011; 226:3385–3391.
47.
ZhangHS, WuMR: SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. Virus Res, 2009; 146:51–57.
48.
ShirakawaK, Takaori-KondoA, YokoyamaM, IzumiT, MatsuiM, IoK, SatoT, SatoH, UchiyamaT: Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol, 2008; 15:1184–1191.
49.
FrancisAC, Di PrimioC, AllouchA, CeresetoA: Role of phosphorylation in the nuclear biology of HIV-1. Curr Med Chem, 2011; 18:2904–2912.
50.
BarnitzRA, WanF, TripuraneniV, BoltonDL, LenardoMJ: Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection. J Virol, 2010; 84:6410–6424.
51.
NisoleS, StoyeJP, SaibA: TRIM family proteins: Retroviral restriction and antiviral defence. Nat Rev Microbiol, 2005; 3:799–808.
BergonziniV, CalistriA, SalataC, Del VecchioC, SartoriE, ParolinC, PaluG: Nef and cell signaling transduction: A possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia. J Neurovirol, 2009; 15:238–248.
RaposoRA, Abdel-MohsenM, BilskaM, MontefioriDC, NixonDF, PillaiSK: Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. J Virol, 2013; 87:11924–11929.
56.
BrassAL, DykxhoornDM, BenitaY, YanN, EngelmanA, XavierRJ, LiebermanJ, ElledgeSJ: Identification of host proteins required for HIV infection through a functional genomic screen. Science, 2008; 319:921–926.
57.
WonderlichER, LeonardJA, KulpaDA, LeopoldKE, NormanJM, CollinsKL: ADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells. J Virol, 2011; 85:12216–12226.
58.
BlagoveshchenskayaAD, ThomasL, FeliciangeliSF, HungCH, ThomasG: HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell, 2002; 111:853–866.
59.
OzatoK, ShinDM, ChangTH, MorseHC3rd: TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol, 2008; 8:849–860.
60.
van ManenD, van ’t WoutAB, SchuitemakerH: Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. Retrovirology, 2012; 9:70.
61.
Botswana Ministry of Health: 2012 Botswana National HIV & AIDS Treatment Guidelines. Ministry of Health, Gaborone, Botswana, 2012.
62.
World Health Organization: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization, Geneva, June2013. ISBN: 978 92 4 150572 7.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
